by Michael Shulman 04/16/08
Michael Shulman has provided advice on shorting stocks and sectors based on ChangeWave Alliance research for several years to its institutional clients through the ChangeWave Insight service.
Currently, he is the editor of ChangeWave Shorts as well as the ChangeWave Biotech Investor newsletter. Michael has also served as Managing Director of Research for ChangeWave Research for four years where he produced technology and health care research for financial institutions.
Michael joined ChangeWave after spending 20 years in various high-tech industries. Prior to joining ChangeWave, Michael was the CEO of AtYourBusiness.com, now Primewire, a benefits administration Application Service Provider he founded in 1998.
Michael began his career doing in-depth company and market analysis for a variety of companies, building databases and simulation models to estimate the success of various technologies across a wide range of market segments. He moved "inside" the high-tech community as a manager at high-tech companies including AT&T. Michael was an early private investor in several Internet start-ups, notably XOOM.com (went public in 1998 and was bought by NBC in 1999) and brings a unique perspective to the ChangeWave research effort, as a combination of technologist, investor and financial analyst.
Michael currently sits on the Executive Board of NextGen Capital, a venture fund based in Fairfax, Va., Chairman and Board member of Primewire, and sits on the Advisory Boards of Sandbox.com and Brainbench.
He has been published in a variety of trade and general business publications, including CD-ROM Today, Worth Online, The Motley Fool, Bonjour Paris and the Los Angeles Times, and is a frequent guest on CNBC's "Squawk Box."
Michael began work for InvestorPlace Media by performing independent research and financial analysis for several of its publications. Prior to taking on his current role as Editor of the Biotech Investor and Shorts services, he served as Editor of ChangeWave Hedge Fund Investing.
When the banks are losing money, who profits? I'll show you how a 10-point drop in a stock led to a 179% gain on the short side.
Financial Transparency Too Little Too Late?
The long, drawn-out and certainly painful credit crisis that's rocking the stock market and the economy has caused many of the 'big boys' to buckle down and admit that they'd gotten hit.
Declining Dollar Tree Turns Giving Tree
You know what you can get for a buck, besides a hamburger or a candy bar? An incredible short-side position that could turn 500% in a matter of weeks.
A quick quiz -- what are the three things you can short? Check your answers below.
Live Well, Thanks to Dying Companies
If you don't want to buy a company's products or services, you shouldn't buy their stocks.
